title: 111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.
abstract: This document provides general information about somatostatin receptor scintigraphy with (111)In-pentetreotide. This guideline should not be regarded as the only approach to visualise tumours expressing somatostatin receptors or as exclusive of other nuclear medicine procedures useful to obtain comparable results. The aim of this guideline is to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of (111)In-pentetreotide scintigraphy.
authors.affiliation: Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
authors.forename: Emilio
authors.initials: E
authors.lastname: Bombardieri
authors.forename: Valentina
authors.initials: V
authors.lastname: Ambrosini
authors.forename: Cumali
authors.initials: C
authors.lastname: Aktolun
authors.forename: Richard P
authors.initials: RP
authors.lastname: Baum
authors.forename: Angelica
authors.initials: A
authors.lastname: Bishof-Delaloye
authors.forename: Silvana
authors.initials: S
authors.lastname: Del Vecchio
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Maffioli
authors.forename: Luc
authors.initials: L
authors.lastname: Mortelmans
authors.forename: Wim
authors.initials: W
authors.lastname: Oyen
authors.forename: Giovanna
authors.initials: G
authors.lastname: Pepe
authors.forename: Arturo
authors.initials: A
authors.lastname: Chiti
mesh_terms: D005260:Female; D015902:Gamma Cameras; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000235:genetics / Q000378:metabolism; D011247:Pregnancy; D011786:Quality Control; D011877:Radionuclide Imaging / Q000295:instrumentation / Q000379:methods*; D017481:Receptors, Somatostatin / Q000378:metabolism; D012107:Research Design; D013004:Somatostatin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
chemical_list: D017481:Receptors, Somatostatin; D013004:Somatostatin; C081788:pentetreotide
references.citation: Semin Nucl Med. 2002 Apr;32(2):79-83
references.pmid: 11965602
references.citation: N Engl J Med. 1990 Nov 1;323(18):1246-9
references.pmid: 2170840
references.citation: Ann ICRP. 1998;28(3):1-126
references.pmid: 10840563
references.citation: J Nucl Med. 1999 Oct;40(10):1602-8
references.pmid: 10520698
references.citation: J Clin Oncol. 2008 Feb 20;26(6):963-70
references.pmid: 18281671
references.citation: Neuro Endocrinol Lett. 2007 Jun;28(3):250-1
references.pmid: 17627256
references.citation: J Nucl Med. 1999 Apr;40(4):539-53
references.pmid: 10210211
references.citation: J Nucl Med. 1997 Jun;38(6):853-8
references.pmid: 9189129
references.citation: Eur J Nucl Med. 1993 Aug;20(8):716-31
references.pmid: 8404961
references.citation: Pediatr Blood Cancer. 2008 Mar;50(3):561-6
references.pmid: 17387742
references.citation: Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):662-71
references.pmid: 20130859
references.citation: J Nucl Med. 1995 Apr;36(4):542-9
references.pmid: 7699439
references.citation: Cancer Res. 1995 Dec 1;55(23 Suppl):5801s-5804s
references.pmid: 7493349
references.citation: Semin Nucl Med. 1995 Jul;25(3):251-61
references.pmid: 7570044
references.citation: Ann ICRP. 1991;22(3):1-28, v-xxiv
references.pmid: 1845339
references.citation: Eur J Nucl Med. 1998 Sep;25(9):1284-92
references.pmid: 9724378
references.citation: Q J Nucl Med. 2000 Mar;44(1):42-9
references.pmid: 10932600
references.citation: J Nucl Med. 2001 Jul;42(7):1134-8
references.pmid: 11438641
references.citation: Acad Radiol. 2010 Mar;17(3):291-7
references.pmid: 19962915
references.citation: Ann ICRP. 1987;18(1-4):1-377
references.pmid: 3505163
references.citation: Acta Oncol. 1993;32(7-8):783-6
references.pmid: 8305227
references.citation: Anticancer Res. 1997 May-Jun;17(3B):1583-8
references.pmid: 9179198
references.citation: Ann ICRP. 2008;38(1-2):1-197
references.pmid: 19154964
references.citation: Ann Intern Med. 1996 Jul 1;125(1):26-34
references.pmid: 8644985
references.citation: Clin Cancer Res. 1997 Dec;3(12 Pt 1):2385-91
references.pmid: 9815638
references.citation: Clin Endocrinol (Oxf). 2003 Nov;59(5):565-73
references.pmid: 14616879
references.citation: Eur J Nucl Med. 1998 Jun;25(6):639-58
references.pmid: 9618580
references.citation: Clin Nucl Med. 2009 Dec;34(12):869-73
references.pmid: 20139819
references.citation: Eur Radiol. 1997;7(7):1103-9
references.pmid: 9265684
references.citation: J Nucl Med. 1996 Sep;37(9):1452-6
references.pmid: 8790191
references.citation: Eur J Nucl Med. 1998 Jul;25(7):675-86
references.pmid: 9662588
references.citation: Eur J Nucl Med. 1998 Oct;25(10):1396-403
references.pmid: 9818279
references.citation: Eur J Nucl Med. 1993 Apr;20(4):283-92
references.pmid: 8491220
references.citation: Neuroendocrinology. 2009;90(2):184-9
references.pmid: 19713709